Results 61 to 70 of about 6,803 (197)

Sugammadex Anaphylaxis: mechanisms, diagnosis, and incidence [PDF]

open access: yes
Sugammadex anaphylaxis is uncommon but potentially life-threatening, and the compounding risk associated with rocuronium allergy must be considered.
Silversides, Jonathan A; id_orcid   +2 more
core   +1 more source

Comparison of the Effect of Sugammadex and Pyridostigmine on Postoperative Catheter-Related Bladder Discomfort: A Retrospective Matched Cohort Analysis

open access: yesMedicina, 2022
Background and Objectives: As the use of sugammadex for reversing neuromuscular blockade during general anesthesia increases, additional effects of sugammadex have been reported compared to cholinesterase inhibitors.
Young-Suk Kwon   +4 more
doaj   +1 more source

Ephedrine for Reducing Onset Time of Rocuronium in Elderly Patients: A Randomised Study

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 10, November 2026.
ABSTRACT Introduction Onset time of rocuronium is prolonged in elderly patients compared to younger patients. Ephedrine reduces onset time of rocuronium in younger adults, but in elderly patients, the effect of ephedrine on onset time of rocuronium has not been investigated.
Matias Vested   +10 more
wiley   +1 more source

Comparison of Sugammadex and Neostigmine in Terms of Time to Extubation in Pediatrics

open access: yes, 2016
Aim: Sugammadex is a cyclodextrin compound which provides complete recovery of residual neuromuscular blockade. In this study, we compared sugammadex and neostigmine in terms of time to achieve a train-of-four (TOF) ratio of 0.9 and extubation time (TE).
Kaya, Guner   +9 more
core   +1 more source

Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysis

open access: yesTherapeutic Advances in Drug Safety, 2019
Introduction: Sugammadex is used for the reversal of neuromuscular blockade caused by rocuronium bromide and vecuronium bromide. As part of the post licensing phase of drug development, adverse events related to the use of sugammadex are still being ...
Pushkar Aggarwal
doaj   +1 more source

Staggering the dose of sugammadex lowers risks for severe emergence cough: a randomized control trial

open access: yesBMC Anesthesiology, 2017
Background Cough on emergence has been reported as a common adverse reaction with sugammadex reversal. We investigated if staggering the dose of sugammadex will reduce emergence cough in a single-center, randomized, double-blinded study.
Loh P.S.   +3 more
doaj   +1 more source

Supramolecular Degraders: An Emerging Paradigm in Targeted Protein Degradation

open access: yesAdvanced Science, Volume 13, Issue 58, 19 October 2026.
Dynamic supramolecular assembly reshapes targeted protein degradation by coordinating modular degrader construction, delivery, functional integration, and intracellular assembly or activation across proteasomal, endosomal–lysosomal, and autophagy–lysosomal pathways.
Kongjun Liu   +8 more
wiley   +1 more source

Effects of rocuronium-induced neuromuscular blockade with sugammadex on diaphragm in rats

open access: yes, 2022
Aim: Sugammadex is a recently developed ?-cyclodextrin agent that can reverse the\reffects of blockers such as rocuronium used to maintain non-depolarizing neuromuscular\rblockade.
Doğukan, Mevlüt, Duran, Mehmet
core   +1 more source

Sugammadex-induced anaphylactic reaction: A systematic review

open access: yesJournal of Anaesthesiology Clinical Pharmacology, 2022
Perioperative anaphylaxis is a rare, but life-threatening hypersensitivity reaction for patients undergoing surgical procedures. Sugammadex is a relatively new drug used to reverse the neuromuscular blockade of specific anesthetics in surgery.
Fatih Zecic   +4 more
doaj   +1 more source

Myasthenia Gravis and Thymoma

open access: yesMuscle &Nerve, Volume 74, Issue 4, Page 1156-1173, October 2026.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy